|
WO2013119326A1
|
|
Neuropsychiatric test reports
|
|
WO2012149535A1
|
|
The use of angiotensin ii (at ii) type 1 receptor antagonist in the therapeutic treatment of autism
|
|
WO2012135400A1
|
|
Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
|
|
WO2012135119A1
|
|
Biomarker-based detection and treatment of neurodegenerative depression
|
|
US2012136680A1
|
|
Neuropsychiatric test reports
|
|
WO2012106524A2
|
|
Diagnosis and treatment of the prodromal schizophrenic state
|
|
WO2012061808A2
|
|
Neuropsychiatric test reports
|
|
WO2012024293A2
|
|
Medical foods for the treatment of developmentally-based neuropsychiatric disorders via modulation of brain glycine and glutathione pathways
|
|
WO2012006329A2
|
|
Apoe4 and apoj biomarker-based prevention and treatment of dementia
|
|
EP2435586A2
|
|
Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
|
